Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

TMCI

Treace Medical Concepts Inc

Feb 11 • 10:29AM ET

1.99

-0.10 -4.79 %

Healthcare • Medical Devices • USA • NASD

Peers: MDT JNJ BSX ZBH SYK GMED EW HOLX IART AIRS

| Held by: IWM VTI VXF IWO VTWO SCHA VHT DFAS ITOT VTWG

Index	RUT	P/E	-	EPS (ttm)	-0.79	Insider Own	30.32%	Shs Outstand	63.70M	Perf Week	-6.14%
Market Cap	126.79M	Forward P/E	-	EPS next Y	-0.85	Insider Trans	0.00%	Shs Float	44.40M	Perf Month	-28.93%
Enterprise Value	139.74M	PEG	-	EPS next Q	-0.15	Inst Own	57.47%	Short Float	7.31%	Perf Quarter	-44.10%
Income	-50.11M	P/S	0.58	EPS this Y	-4.24%	Inst Trans	-0.56%	Short Ratio	3.90	Perf Half Y	-69.53%
Sales	218.88M	P/B	1.42	EPS next Y	9.72%	ROA	-24.47%	Short Interest	3.24M	Perf YTD	-18.78%
Book/sh	1.40	P/C	2.21	EPS next 5Y	3.03%	ROE	-51.63%	52W High	10.40 -80.87%	Perf Year	-80.10%
Cash/sh	0.90	P/FCF	-	EPS past 3/5Y	-32.84% -56.40%	ROIC	-32.19%	52W Low	2.02 -1.25%	Perf 3Y	-90.53%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	30.40% 39.65%	Gross Margin	79.87%	Volatility	8.13% 6.84%	Perf 5Y	-
Dividend TTM	-	EV/Sales	0.64	EPS Y/Y TTM	19.92%	Oper. Margin	-22.13%	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.36	Sales Y/Y TTM	7.90%	Profit Margin	-22.89%	RSI (14)	31.64	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.37	EPS Q/Q	-3.89%	SMA20	-16.37%	Beta	0.75	Target Price	5.40
Payout	-	Debt/Eq	0.79	Sales Q/Q	11.37%	SMA50	-22.12%	Rel Volume	0.51	Prev Close	2.09
Employees	477	LT Debt/Eq	0.75	Earnings	Feb 26 AMC	SMA200	-61.84%	Avg Volume	832.70K	Price	1.99
IPO	Apr 23, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.66% 0.77%	Trades		Volume	83,000	Change	-4.79%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-07-25	Downgrade	JP Morgan	Neutral → Underweight	$5
Nov-07-25	Downgrade	BTIG Research	Buy → Neutral
Feb-04-25	Upgrade	BTIG Research	Neutral → Buy	$16
Dec-31-24	Initiated	Lake Street	Buy	$14.50
Dec-17-24	Resumed	JP Morgan	Neutral	$8
May-16-24	Downgrade	UBS	Buy → Neutral	$16 → $6.50
May-08-24	Downgrade	Truist	Buy → Hold	$17 → $7
May-08-24	Downgrade	Stifel	Buy → Hold	$15 → $6
May-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$15 → $5.50
May-08-24	Downgrade	JP Morgan	Overweight → Neutral	$15 → $8
May-08-24	Downgrade	BTIG Research	Buy → Neutral
Sep-29-23	Initiated	UBS	Buy	$24
May-01-23	Initiated	Truist	Buy	$33
Apr-11-23	Initiated	Stephens	Equal-Weight	$26
May-12-22	Initiated	BTIG Research	Buy	$22
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$30
May-18-21	Initiated	SVB Leerink	Outperform	$38
May-18-21	Initiated	Stifel	Buy	$35
May-18-21	Initiated	Morgan Stanley	Equal-Weight	$30
May-18-21	Initiated	JP Morgan	Overweight	$37

Show Previous Ratings

Feb-09-26 02:15PM	Stifel Revises Treace Medical Concepts, Inc. (TMCI) Price Target in Sector-Wide Update (Insider Monkey)
Jan-13-26 07:05AM	Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue (GlobeNewswire)
Jan-08-26 04:05PM	Treace Announces First Surgical Case Utilizing Lapiplasty Lightning Technology (GlobeNewswire)
Dec-30-25 04:05PM	Treace to Present at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-18-25 08:30AM	Treace Medical Secures Up to $175 Million in Debt Financing (GlobeNewswire)
08:05AM	Loading…
Nov-07-25 08:05AM	Treace Announces Participation in Two Upcoming Investor Conferences (GlobeNewswire) -28.33%
Nov-06-25 05:40PM	Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:34PM	Treace Medical Concepts: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Treace Medical Concepts Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-05-25 07:50AM	What To Expect From Treace Medical Concepts Inc (TMCI) Q3 2025 Earnings (GuruFocus.com)
Oct-23-25 04:05PM	Treace to Report Third Quarter 2025 Financial Results on November 6, 2025 (GlobeNewswire)
Sep-10-25 07:05AM	Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting (GlobeNewswire) -5.41%
Aug-08-25 09:01PM	Treace Medical Concepts Inc (TMCI) Q2 2025 Earnings Call Highlights: Revenue Growth and ... (GuruFocus.com) +7.92%
Aug-07-25 06:05PM	Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:03PM	Treace Medical Concepts: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Treace Medical Concepts Reports Second Quarter 2025 Financial Results (GlobeNewswire)
04:01PM	Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025 (GlobeNewswire)
Aug-05-25 04:05PM	Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D Lapiplasty Multicenter Prospective Clinical Study (GlobeNewswire)
Aug-04-25 05:35PM	Tactile Systems Technology (TCMD) Surpasses Q2 Earnings and Revenue Estimates (Zacks) +5.06%
Jul-24-25 04:05PM	Treace to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jun-05-25 01:00PM	Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty Bunion Technology (GlobeNewswire)
May-30-25 05:45AM	Shareholders of Treace Medical Concepts, Inc. Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your Rights - TMCI (PR Newswire)
May-13-25 09:55AM	Wall Street Analysts See a 41.11% Upside in Treace Medical Concepts (TMCI): Can the Stock Really Move This High? (Zacks)
May-09-25 11:55AM	Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against Treace Medical Concepts, Inc. (TMCI) (Newsfile) -9.55%
10:15AM	Q1 2025 Treace Medical Concepts Inc Earnings Call (Thomson Reuters StreetEvents)
05:45AM	Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your Rights - TMCI (PR Newswire)
03:43AM	Treace Medical Concepts Inc (TMCI) Q1 2025 Earnings Call Highlights: Strategic Innovations and ... (GuruFocus.com)
May-08-25 06:15PM	Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:22PM	Treace Medical Concepts: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Treace Medical Concepts Reports First Quarter 2025 Financial Results (GlobeNewswire)
06:55PM	Loading…
May-07-25 06:55PM	Veracyte (VCYT) Q1 Earnings and Revenues Beat Estimates (Zacks)
11:55AM	Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Action Has Been Filed Against Treace Medical Concepts, Inc. (TMCI) (Newsfile)
10:54AM	What To Expect From Treace Medical Concepts Inc (TMCI) Q1 2025 Earnings (GuruFocus.com)
May-06-25 08:35AM	Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-25-25 05:45AM	Shareholders of Treace Medical Concepts, Inc. Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your Rights - TMCI (PR Newswire)
Apr-24-25 04:05PM	Treace to Report First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Apr-18-25 05:45AM	Shareholders of Treace Medical Concepts, Inc. Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your Rights - TMCI (PR Newswire)
Apr-07-25 10:08AM	Treace Medical Concepts: No Solid Footing (Seeking Alpha)
08:00AM	Treace Announces Upcoming Board Chair Transition (GlobeNewswire)
Mar-28-25 02:00PM	Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty and Adductoplasty Outcomes at the 2025 ACFAS Annual Scientific Conference (GlobeNewswire)
Mar-25-25 04:15PM	Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference (GlobeNewswire)
Feb-28-25 07:24AM	Q4 2024 Treace Medical Concepts Inc Earnings Call (Thomson Reuters StreetEvents)
02:40AM	Treace Medical Concepts Inc (TMCI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Feb-27-25 06:25PM	Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -5.88%
05:28PM	Treace Medical Concepts: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Treace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial Results (GlobeNewswire)
Feb-26-25 08:02AM	What To Expect From Treace Medical Concepts Inc (TMCI) Q4 2024 Earnings (GuruFocus.com)
Feb-06-25 04:15PM	Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025 (GlobeNewswire)
Feb-04-25 03:17PM	Why Treace Medical Concepts (TMCI) Is Rallying Today (Insider Monkey) +8.46%
Jan-30-25 08:00AM	Treace Announces First Surgical Cases Utilizing the SpeedAkin Anatomic Compression Implant (GlobeNewswire)
Jan-13-25 08:00AM	Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue (GlobeNewswire) +14.52%
Jan-02-25 04:15PM	Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +5.78%
Dec-30-24 08:15AM	Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty Percutaneous 3D Bunion Correction Procedure (GlobeNewswire)
Dec-19-24 07:37AM	Treace Medical price target raised to $8.40 from $7 at Truist (TipRanks)
Dec-16-24 08:30AM	Treace Announces First Surgical Cases Utilizing the SpeedPlate MicroQuad Implant (GlobeNewswire)
Dec-04-24 04:15PM	Treace Announces First Cases Utilizing RedPoint Intelliguide Patient Specific Instrumentation with the Adductoplasty System for Correction of Midfoot Deformities (GlobeNewswire) -5.73%
Dec-02-24 04:15PM	Treace Appoints Guy Guglielmino as Chief Commercial Officer (GlobeNewswire)
Nov-18-24 04:46PM	Treace Announces Participation at Stifel 2024 Healthcare Conference (GlobeNewswire) +5.29%
Nov-06-24 10:09AM	Q3 2024 Treace Medical Concepts Inc Earnings Call (Thomson Reuters StreetEvents) +35.07%
02:22AM	Treace Medical Concepts Inc (TMCI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-05-24 05:25PM	Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +6.08%
04:21PM	Treace Medical Concepts: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Treace Medical Concepts Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-04-24 05:29PM	Treace Announces Participation in the UBS Global Healthcare Conference (GlobeNewswire) +13.60%
08:00AM	Treace Comments on CMS' 2025 Final Rule for Hospital Outpatient and ASC Settings (GlobeNewswire)
07:12AM	Treace Medical Concepts Inc (TMCI) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
07:00AM	Treace Enters High Volume Osteotomy Market with Nanoplasty 3D Minimally Invasive Bunion Correction Procedure (GlobeNewswire)
Oct-22-24 04:30PM	Treace to Report Third Quarter 2024 Financial Results on November 5, 2024 (GlobeNewswire)
Oct-14-24 09:45AM	Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty Bunion Technology (GlobeNewswire)
Oct-09-24 05:08PM	Treace Medical Concepts Inc (TMCI) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ... (GuruFocus.com)
Sep-18-24 10:53AM	Treace Medical Concepts (TMCI) Slid on Reduced Guidance (Insider Monkey) +5.18%
Sep-11-24 08:00AM	Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024 (GlobeNewswire)
Aug-22-24 04:15PM	Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-06-24 07:00PM	Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +5.21%
05:53PM	Treace Medical Concepts: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Treace Medical Concepts Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-18-24 04:30PM	Treace to Report Second Quarter 2024 Financial Results on August 6, 2024 (GlobeNewswire) -6.52%
May-28-24 07:00AM	Treace to Present at Truist Securities MedTech Conference (GlobeNewswire)
May-16-24 10:05AM	UBS Downgrades Treace Medical Concepts to Neutral From Buy, Cuts Price Target to $6.50 From $16 (MT Newswires) -5.38%
May-15-24 03:11AM	Director Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI) (GuruFocus.com) +19.00%
May-14-24 03:09AM	Director Deepti Jain Acquires 25,000 Shares of Treace Medical Concepts Inc (TMCI) (GuruFocus.com) +10.38%
03:08AM	Director Richard Mott Acquires 120,000 Shares of Treace Medical Concepts Inc (TMCI) (GuruFocus.com)
May-13-24 09:58AM	Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 03:13PM	Top Midday Decliners (MT Newswires) -62.50%
10:28AM	UBS Adjusts Price Target on Treace Medical Concepts to $16 From $17, Maintains Buy Rating (MT Newswires)
08:34AM	Why Is Treace Medical Concepts (TMCI) Stock Down 59% Today? (InvestorPlace)
07:42AM	Top Premarket Decliners (MT Newswires)
07:31AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
06:44AM	--BTIG Downgrades Treace Medical Concepts to Neutral From Buy (MT Newswires)
03:56AM	Treace Medical Concepts Inc (TMCI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-07-24 09:57PM	TMCI Stock Earnings: Treace Medical Concepts Meets EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:15PM	Treace Medical Concepts Inc (TMCI) Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss Widens (GuruFocus.com)
05:30PM	Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:38PM	Treace Medical Concepts: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Treace Medical Concepts Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-24-24 07:00AM	Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour (GlobeNewswire)
Apr-17-24 07:00AM	Treace to Present at Bank of America Health Care Conference (GlobeNewswire)
Apr-16-24 07:00AM	Treace Announces First Annual National Bunion Day (GlobeNewswire)
Apr-09-24 07:00AM	Treace to Report First Quarter 2024 Financial Results (GlobeNewswire)
Mar-25-24 07:00AM	Treace Celebrates 100,000 Lapiplasty 3D Bunion Correction Patient Milestone (GlobeNewswire)

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Scanlan Sean F.	Chief Innovation Officer	Jan 21 '26	Option Exercise	0.72	53,500	38,520	427,099	Jan 23 09:30 PM
Scanlan Sean F.	Chief Innovation Officer	Jul 18 '25	Option Exercise	0.72	33,437	24,001	383,621	Jul 22 05:00 PM
Scanlan Sean F.	Chief Innovation Officer	Mar 17 '25	Option Exercise	1.05	50,000	52,500	414,081	Mar 19 09:30 PM
Scanlan Sean F.	Chief Innovation Officer	Mar 17 '25	Sale	7.97	50,000	398,460	364,081	Mar 19 09:30 PM
SEAN SCANLAN	Officer	Mar 17 '25	Proposed Sale	7.95	50,000	397,500		Mar 17 04:44 PM
Treace John T.	Chief Executive Officer	Mar 04 '25	Buy	8.73	60,000	524,064	6,796,190	Mar 04 06:30 PM

Open in Screener

STIM

Neuronetics Inc

Feb 11 • 10:29AM ET

1.66

+0.20 14.04 %

Healthcare • Medical Devices • USA • NASD

Peers: COHR NOVA NVCR GNFT XFOR XERS SENS BLDR CANF

| Held by: VTI IWM VXF PSIL IWO VTWO IWC QQQS VTWG RSSL

Index	RUT	P/E	-	EPS (ttm)	-0.82	Insider Own	50.77%	Shs Outstand	68.44M	Perf Week	7.42%
Market Cap	114.03M	Forward P/E	-	EPS next Y	-0.46	Insider Trans	-9.15%	Shs Float	33.72M	Perf Month	-15.91%
Enterprise Value	174.13M	PEG	-	EPS next Q	-0.11	Inst Own	31.41%	Short Float	25.47%	Perf Quarter	-22.20%
Income	-44.00M	P/S	0.88	EPS this Y	56.57%	Inst Trans	3.59%	Short Ratio	5.00	Perf Half Y	-56.87%
Sales	129.87M	P/B	4.17	EPS next Y	22.77%	ROA	-40.07%	Short Interest	8.59M	Perf YTD	20.65%
Book/sh	0.40	P/C	3.29	EPS next 5Y	37.99%	ROE	-239.53%	52W High	5.92 -71.88%	Perf Year	-57.63%
Cash/sh	0.51	P/FCF	-	EPS past 3/5Y	-4.00% 2.71%	ROIC	-39.10%	52W Low	1.25 33.20%	Perf 3Y	-69.51%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.63% 3.63%	Gross Margin	48.01%	Volatility	15.70% 11.66%	Perf 5Y	-90.62%
Dividend TTM	-	EV/Sales	1.34	EPS Y/Y TTM	32.39%	Oper. Margin	-28.75%	ATR (14)	0.23	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.09	Sales Y/Y TTM	78.62%	Profit Margin	-33.88%	RSI (14)	46.32	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.24	EPS Q/Q	69.51%	SMA20	-11.32%	Beta	0.84	Target Price	6.50
Payout	-	Debt/Eq	3.32	Sales Q/Q	101.28%	SMA50	0.13%	Rel Volume	23.91	Prev Close	1.46
Employees	716	LT Debt/Eq	3.11	Earnings	Nov 04 BMO	SMA200	-43.40%	Avg Volume	1.72M	Price	1.66
IPO	Jun 28, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-4.17% -1.36%	Trades		Volume	7,949,288	Change	14.04%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-13-24	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy	$11
Jul-24-18	Initiated	Canaccord Genuity	Buy

Today 12:20AM	Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On? (Benzinga) +14.04%
Feb-10-26 04:34PM	Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Nov-20-25 08:30AM	Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire) -12.75%
Nov-12-25 10:33AM	TRICARE West Expands NeuroStar TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression (GlobeNewswire)
Nov-04-25 04:08PM	Neuronetics Inc (STIM) Q3 2025 Earnings Call Highlights: Revenue Surges Amid Strategic Acquisitions (GuruFocus.com)
08:40AM	Loading…
08:40AM	Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:39AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan (GlobeNewswire)
Nov-03-25 08:09AM	Neuronetics Inc (STIM) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-31-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-30-25 08:32AM	Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence (GlobeNewswire) -6.90%
Oct-21-25 08:30AM	Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire) +5.49%
Sep-17-25 08:32AM	New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar Advanced Therapy, to Treat Major Depressive Disorder (MDD) (GlobeNewswire)
Sep-02-25 03:49AM	Neuronetics, Inc. (STIM) Positions as Neurohealth Leader with Adolescent Breakthrough (Insider Monkey) -5.71%
Aug-06-25 04:45PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.60% -5.65%
08:20AM	Loading…
Aug-05-25 08:20AM	Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:19AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Neuronetics Reports Second Quarter 2025 Financial and Operating Results (GlobeNewswire)
Aug-04-25 04:30PM	Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire) +5.43%
10:04AM	What To Expect From Neuronetics Inc (STIM) Q2 2025 Earnings (GuruFocus.com)
Jul-30-25 08:32AM	NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents (GlobeNewswire)
Jul-22-25 08:30AM	Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire) +8.76%
Jul-15-25 07:30AM	Neuronetics Appoints New Chief Financial Officer (GlobeNewswire)
Jul-09-25 07:20AM	Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting (Insider Monkey)
Jun-19-25 07:00PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-10-25 08:31AM	Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program (GlobeNewswire)
Jun-02-25 04:30PM	Neuronetics Set to Join Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
May-14-25 08:31AM	Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month (GlobeNewswire)
May-07-25 03:09AM	Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges (GuruFocus.com)
May-06-25 08:20AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:20AM	Loading…
07:20AM	Neuronetics: Q1 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports First Quarter 2025 Financial and Operating Results (GlobeNewswire)
May-05-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:40AM	Integra LifeSciences (IART) Q1 Earnings Miss Estimates (Zacks)
Apr-30-25 05:50AM	Why Neuronetics, Inc. (STIM) is Surging in 2025 (Insider Monkey)
Apr-22-25 08:30AM	Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-02-25 03:26PM	BrainsWay: Strong Growth Prospects Matter Little To The Market (Seeking Alpha)
Mar-31-25 08:31AM	Evernorth Health Services, a Cigna Company, Expands NeuroStar TMS Coverage for Adolescents Struggling with Depression (GlobeNewswire)
Mar-29-25 11:45PM	Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (Seeking Alpha)
Mar-27-25 04:30PM	Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire) -5.75%
Mar-18-25 09:55AM	Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet (Zacks)
Mar-05-25 02:06AM	Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... (GuruFocus.com) +7.11%
Mar-04-25 11:29PM	Q4 2024 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) +18.78%
07:36AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-03-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:20AM	Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-22-25 05:08PM	Neuronetics, Inc. (STIM): Among the Hot Penny Stocks to Buy Now (Insider Monkey)
Feb-21-25 08:30AM	Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) -13.96%
Feb-07-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -13.76% +25.73%
07:54AM	Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Feb-06-25 04:23PM	Neuronetics Announces Launch of Underwritten Public Offering of Common Stock (GlobeNewswire) +8.87%
Feb-03-25 07:27PM	Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 (Insider Monkey) +7.81%
Jan-29-25 08:31AM	NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression (GlobeNewswire) +6.31%
Jan-13-25 08:00AM	Neuronetics Provides Business Update and Issues 2025 Guidance (GlobeNewswire) +36.84%
Dec-18-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.38% -5.84%
Dec-16-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +19.27%
Dec-10-24 10:00AM	Neuronetics and Greenbrook TMS Announce Closing of Transaction (GlobeNewswire)
Nov-20-24 08:30AM	Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +6.26%
Nov-13-24 02:10AM	Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ... (GuruFocus.com) -11.65%
Nov-12-24 06:45PM	CORRECTION Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire) -37.27%
04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:20AM	Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:19AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire)
Nov-11-24 07:26AM	Neuronetics Inc (STIM) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com) -5.98%
Oct-29-24 04:30PM	Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) +5.94%
Oct-14-24 08:31AM	NeuroStar Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression (GlobeNewswire)
Oct-04-24 08:33AM	Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings (PR Newswire) +7.58%
Sep-25-24 08:31AM	Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents (GlobeNewswire) -6.18%
Sep-19-24 08:31AM	Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults (GlobeNewswire)
Sep-16-24 08:32AM	NeuroStar Releases Software Upgrades to Elevate Patient Care (GlobeNewswire) +6.70%
Sep-03-24 08:29AM	NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories (GlobeNewswire)
Aug-20-24 08:29AM	NeuroStar Marks Two Years of Transformative Impact with NeuroStar University (GlobeNewswire)
Aug-15-24 05:42AM	Neuronetics inks Greenbrook merger to acquire treatment centers (MedTech Dive) +16.32%
Aug-13-24 12:56PM	Neuronetics' (STIM) Latest Deal to Aid Mental Health Treatments (Zacks)
12:47PM	Neuronetics (STIM) Inks a New Merger Agreement With Greenbrook (Zacks)
09:45AM	Neuronetics (STIM) Q2 Loss Wider Than Expected, Revenues Fall Y/Y (Zacks)
Aug-12-24 08:25AM	Neuronetics (STIM) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -58.15%
07:19AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:15AM	Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge (GlobeNewswire)
07:10AM	Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results (GlobeNewswire)
Aug-05-24 04:36PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-01-24 08:29AM	NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month (GlobeNewswire)
Jul-31-24 08:30AM	Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Jul-30-24 08:30AM	Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors (GlobeNewswire)
Jul-29-24 08:30AM	Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Jul-22-24 08:31AM	Aetna Policy Update Expands TMS Availability for Adolescents With Depression (GlobeNewswire)
Jul-18-24 10:30AM	3 Neurotech Stocks Bridging Mind and Machine (InvestorPlace) -5.00%
Jul-11-24 12:53PM	TMS in California will have Medicaid coverage for major depressive disorder patients (Medical Device Network)
08:36AM	California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults (GlobeNewswire)
Jul-10-24 08:32AM	BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents (GlobeNewswire)
07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Jul-02-24 10:40AM	Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch (Zacks)
Jul-01-24 08:02AM	NeuroStar Launches Better Me Provider Program Nationwide (GlobeNewswire)
Jun-13-24 08:31AM	NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting (GlobeNewswire)
Jun-07-24 02:38AM	Director Robert Cascella Acquires 50,000 Shares of Neuronetics Inc (STIM) (GuruFocus.com) +10.34%
May-23-24 08:30AM	Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference (GlobeNewswire)
May-15-24 07:32AM	Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents (GlobeNewswire)
May-08-24 09:30AM	Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript (Insider Monkey)

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 1998 and is headquartered in Malvern, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MACAN WILLIAM ANDREW	Officer	Feb 10 '26	Proposed Sale	1.55	3,485	5,392		Feb 10 04:28 PM
Sullivan Keith J	Officer	Feb 10 '26	Proposed Sale	1.55	40,976	63,398		Feb 10 04:14 PM
Madryn Asset Management, LP	10% Owner	Aug 08 '25	Sale	3.72	3,500,000	13,020,000	1,142,351	Aug 12 04:15 PM
MADRYN HEALTH PRTS II (CAY MAS	10% Owner	Aug 08 '25	Proposed Sale	3.72	2,925,554	10,883,061		Aug 08 04:55 PM
MADRYN HEALTH PARTNERS II, LP	10% Owner	Aug 08 '25	Proposed Sale	3.72	192,806	717,238		Aug 08 04:54 PM
MADRYN SELECT OPPORTUNITIES, L	10% Owner	Aug 08 '25	Proposed Sale	3.72	381,640	1,419,701		Aug 08 04:54 PM
Furlong Stephen	Officer	Aug 07 '25	Proposed Sale	4.09	98,635	403,385		Aug 07 04:52 PM
Furlong Stephen	EVP, CFO and Treasurer	May 12 '25	Sale	4.27	193,460	826,074	416,593	May 14 05:05 PM
Furlong Stephen	EVP, CFO and Treasurer	May 13 '25	Sale	4.16	6,540	27,206	410,053	May 14 05:05 PM
Furlong Stephen	Officer	May 13 '25	Proposed Sale	4.16	6,540	27,190		May 13 12:54 PM
Furlong Stephen	Officer	May 12 '25	Proposed Sale	4.27	193,460	826,283		May 12 04:40 PM
Furlong Stephen	EVP, CFO and Treasurer	Mar 04 '25	Sale	4.48	1,867	8,364	610,053	Mar 06 05:00 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Mar 04 '25	Sale	4.48	377	1,689	526,805	Mar 06 05:00 PM
MACAN WILLIAM ANDREW	Officer	Mar 04 '25	Proposed Sale	4.48	377	1,688		Mar 04 03:27 PM
Furlong Stephen	Officer	Mar 04 '25	Proposed Sale	4.48	1,867	8,360		Mar 04 03:16 PM
Sullivan Keith J	President and CEO	Feb 19 '25	Sale	4.70	24,440	114,868	1,232,988	Feb 20 05:21 PM
Sullivan Keith J	President and CEO	Feb 18 '25	Sale	4.41	25,934	114,369	1,257,428	Feb 20 05:21 PM
Sullivan Keith J	Officer	Feb 19 '25	Proposed Sale	4.70	24,440	114,760		Feb 19 03:16 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 14 '25	Sale	4.11	18,965	77,946	369,682	Feb 18 05:03 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 14 '25	Sale	4.11	17,307	71,132	454,420	Feb 18 05:02 PM
Sullivan Keith J	Officer	Feb 18 '25	Proposed Sale	4.41	25,934	114,356		Feb 18 03:16 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 12 '25	Sale	3.83	10,845	41,536	471,727	Feb 14 05:00 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 12 '25	Sale	3.83	12,175	46,630	388,647	Feb 14 05:00 PM
Furlong Stephen	Officer	Feb 14 '25	Proposed Sale	4.11	17,307	71,158		Feb 14 03:13 PM
MACAN WILLIAM ANDREW	Officer	Feb 14 '25	Proposed Sale	4.11	18,965	77,975		Feb 14 03:13 PM
Furlong Stephen	Officer	Feb 12 '25	Proposed Sale	3.83	10,845	41,554		Feb 12 03:17 PM
MACAN WILLIAM ANDREW	Officer	Feb 12 '25	Proposed Sale	3.83	12,175	46,650		Feb 12 03:08 PM

TMCI

Treace Medical Concepts Inc

STIM

Neuronetics Inc

Upgrade your FINVIZ experience